Blockchain Startup

The next evolution of drug development




Molecule is a software platform to accelerate innovation in the pharmaceutical industry. It connects scientists, patients and industry to advance drug development in a collaborative open market.

The Molecule Protocol is an open platform led by an international team comprised of scientists, economists, software engineers and industry experts. The protocol enables new economic incentive models for distributed research and development. We leverage open science and blockchain technology to create a fair and accountable market-based platform for discovery and funding of pharmaceutical intellectual property. The ecosystem aims to align all stakeholders - academia, pharmaceutical corporations, consumers, biotech companies, investors, regulators, and lawyers - to collaborate in an open, incentive-based market.

Category Health
Name Linum Labs
Founding Date 2018-7-5
Token Offering No
Technology Blockchain
Investors n/a
Job Offers n/a
Looking for Investors n/a
Looking for Equity Investors n/a
Looking for Speaking Opportunities n/a
Related Startups SIRIN Labs

Report wrong data!

Founders of Molecule

Paul Kohlhaas (CEO)